Lercanidipine improves its antihypertensive effectiveness with no impairment on its good tolerability profile in higher-risk hypertensives. the laura study
Author(s) -
Vivencio Barrios
Publication year - 2004
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1016/j.amjhyper.2004.03.256
Subject(s) - lercanidipine , tolerability , medicine , clinical practice , antihypertensive drug , randomized controlled trial , drug , clinical trial , pharmacology , blood pressure , adverse effect , physical therapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom